EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Scope & Guideline

Transforming Clinical Insights into Endocrine Solutions

Introduction

Welcome to your portal for understanding EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0947-7349
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1983 to 2024
AbbreviationEXP CLIN ENDOCR DIAB / Exp. Clin. Endocrinol. Diabet.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

The journal 'EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES' focuses on the intersection of endocrinology and diabetes, publishing research that spans a wide range of topics within these fields. Its aim is to advance understanding, diagnosis, and treatment of endocrine disorders, particularly those related to diabetes.
  1. Endocrine Disorders and Diabetes Management:
    The journal extensively covers research related to various endocrine disorders, including diabetes mellitus types 1 and 2, Cushing's syndrome, adrenal insufficiency, and thyroid disorders. It aims to provide insights into the pathophysiology, diagnosis, and management of these conditions.
  2. Clinical Trials and Therapeutic Interventions:
    A significant emphasis is placed on clinical trials and therapeutic interventions, including pharmacological treatments, lifestyle interventions, and surgical approaches. This includes studies on the efficacy and safety of new drugs and treatment regimens for managing diabetes and its complications.
  3. Molecular and Genetic Research:
    The journal publishes research that explores the molecular mechanisms underlying endocrine disorders and diabetes. This includes genetic studies, biomarker identification, and investigations into metabolic pathways that influence disease progression.
  4. Public Health and Epidemiology:
    Research addressing the public health aspects of diabetes and endocrine disorders is also featured. This includes epidemiological studies that explore the prevalence, risk factors, and socio-economic impacts of these diseases.
  5. Innovative Diagnostic Techniques and Technologies:
    The journal highlights advancements in diagnostic techniques and technologies, such as continuous glucose monitoring, imaging modalities, and genetic testing, which facilitate better management of diabetes and other endocrine disorders.
The journal has seen an increase in research themes that reflect current trends and emerging areas of interest in endocrinology and diabetes. These trends indicate a shift towards more innovative and integrative approaches to disease management.
  1. Personalized Medicine and Genomics:
    There is a noticeable trend towards personalized medicine, with an emphasis on genomic research and tailored therapies for diabetes management, highlighting the importance of genetic factors in treatment responses.
  2. Technological Innovations in Diabetes Management:
    Emerging themes include the use of advanced technologies such as continuous glucose monitoring systems, telemedicine, and mobile health applications, reflecting a shift towards more accessible and effective diabetes care.
  3. Psychosocial Aspects of Diabetes Care:
    Research focusing on the psychosocial factors affecting diabetes management, including mental health, quality of life, and patient education, is gaining traction, emphasizing holistic approaches to treatment.
  4. Metabolic Syndrome and Comorbidities:
    Studies exploring the interplay between diabetes, metabolic syndrome, and related comorbidities such as cardiovascular diseases and obesity are increasingly prominent, indicating a broader understanding of diabetes as part of a larger metabolic landscape.
  5. Impact of COVID-19 on Diabetes Management:
    The ongoing research into the impact of the COVID-19 pandemic on diabetes patients, including changes in management strategies and healthcare access, represents a significant emerging theme in the journal.

Declining or Waning

While the journal maintains a broad focus on endocrinology and diabetes, certain themes appear to be declining in prominence based on the recent publication trends. These waning areas may indicate shifts in research priorities or emerging interests in the field.
  1. Traditional Dietary Approaches:
    Research focusing on traditional dietary recommendations for diabetes management appears to be declining, as newer studies emphasize personalized nutrition and the effects of specific dietary patterns on metabolic health.
  2. Basic Science of Diabetes Complications:
    There seems to be a waning interest in basic science research solely focused on complications associated with diabetes, such as retinopathy and nephropathy, as more studies shift towards integrative approaches that encompass lifestyle and psychosocial factors.
  3. Generalized Diabetes Education:
    Papers centered around generalized diabetes education strategies without specific innovations or targeted interventions are becoming less frequent, as the focus shifts towards more personalized and technology-driven education methods.
  4. Epidemiological Studies without Local Context:
    Epidemiological studies that lack a localized context or do not address specific populations are declining, as there is a growing recognition of the importance of culturally and regionally relevant research in understanding diabetes.

Similar Journals

ACTA DIABETOLOGICA

Pioneering Research in Endocrinology and Diabetes
Publisher: SPRINGER-VERLAG ITALIA SRLISSN: 0940-5429Frequency: 12 issues/year

ACTA DIABETOLOGICA, published by SPRINGER-VERLAG ITALIA SRL, is a distinguished peer-reviewed journal dedicated to the rapidly evolving fields of endocrinology, diabetes, and metabolism. With an impressive convergence of research from 1991 to 2024, it is recognized for its significant contributions, boasting a Q1 ranking in Internal Medicine and Q2 rankings in Endocrinology categories as of 2023. Its Scopus rankings further highlight its impact, placing it in the 81st percentile in Internal Medicine. The journal serves as a vital platform for professionals and researchers, facilitating the dissemination of innovative findings and fostering a comprehensive understanding of metabolic disorders. Although the journal is not open access, it remains an essential resource, ensuring high visibility and accessibility of critical research to its scholarly audience.

Diabetology & Metabolic Syndrome

Leading the charge in open-access endocrinology.
Publisher: BMCISSN: Frequency: 1 issue/year

Diabetology & Metabolic Syndrome is a premier open-access journal published by BMC, dedicated to advancing the field of endocrinology, diabetes, and metabolic syndrome. Since its inception in 2009, the journal has established itself as a leading platform for original research, reviews, and clinical studies, offering comprehensive insights into the complexities of metabolic diseases. With an impressive ranking in the 2023 category quartiles as Q1 in both Endocrinology, Diabetes and Metabolism, and Internal Medicine, it stands among the top-tier journals in its field. Researchers will appreciate its strong emphasis on disseminating critical findings that influence clinical practices and public health policies. Accessible to a global audience, Diabetology & Metabolic Syndrome's commitment to open access enables the distribution of high-quality research without barriers, fostering an inclusive environment for knowledge sharing. With a strategic focus on the intersection of diabetes management and metabolic disorders, this journal is essential for professionals seeking to stay abreast of the latest developments and contribute to a vital area of healthcare.

ENDOCRINE RESEARCH

Pioneering discoveries in endocrine health.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

Hormones-International Journal of Endocrinology and Metabolism

Advancing the Frontiers of Hormonal Science
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

ANNALES D ENDOCRINOLOGIE

Exploring Hormonal Frontiers: Insights from 1946 to Today
Publisher: MASSON EDITEURISSN: 0003-4266Frequency: 6 issues/year

ANNALES D ENDOCRINOLOGIE is a prestigious academic journal dedicated to the vibrant field of endocrinology, encompassing key aspects of diabetes and metabolism. Published by MASSON EDITEUR, this journal has been a vital resource for researchers and healthcare professionals since its inception in 1946. With its impressive Q2 ranking in the Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) categories, it showcases a wealth of high-quality research, reviews, and contributions that push the boundaries of endocrinological science. Although not open access, the journal maintains a significant impact on the academic community, with ongoing discussion and dissemination of pivotal advancements. The comprehensive coverage from 1946 to 2024 ensures that a broad spectrum of hormonal disorders, therapeutic innovations, and metabolic health issues are thoroughly explored, reflecting its commitment to enhancing knowledge and clinical practice in endocrinology. By engaging with this journal, researchers, clinicians, and students alike can stay informed of the latest trends and discoveries within the endocrine field.

Journal of the ASEAN Federation of Endocrine Societies

Advancing Endocrinology: Bridging Knowledge Across ASEAN
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

JOURNAL OF DIABETES AND ITS COMPLICATIONS

Exploring the complexities of diabetes and its impact.
Publisher: ELSEVIER SCIENCE INCISSN: 1056-8727Frequency: 6 issues/year

JOURNAL OF DIABETES AND ITS COMPLICATIONS is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the knowledge and management of diabetes and its multifaceted complications. With an ISSN of 1056-8727 and E-ISSN 1873-460X, this journal has established its significance in the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine, as reflected in its Q2 and Q1 quartile rankings for 2023, and its commendable Scopus rankings. The journal, which has been converging knowledge since 1992 and continues to publish vital research until 2024, serves as a platform for researchers, professionals, and students aiming to delve deeper into the mechanisms, treatment, and implications of diabetes and its related disorders. While access is not open, the journal remains a critical resource for those invested in understanding and combating the challenges posed by diabetes, ultimately contributing to better health outcomes.

Minerva Endocrinology

Advancing the Frontiers of Endocrinology and Metabolism
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-6507Frequency: 4 issues/year

Minerva Endocrinology, published by EDIZIONI MINERVA MEDICA in Italy, serves as a pivotal platform for advancing knowledge in the field of endocrinology, diabetes, and metabolism. With its ISSN 2724-6507 and E-ISSN 2724-6116, the journal has rapidly established a reputable position in academia, achieving impressive rankings such as Q3 in both Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. This enables Minerva Endocrinology to attract a diverse readership, including researchers, healthcare professionals, and students committed to understanding the complexities of endocrine disorders. With annual publications covering breakthroughs and innovative research covering converged years from 2021 to 2024, the journal is devoted to facilitating the dissemination of high-quality studies that advance clinical and laboratory practices. Despite its >Open Access< status, the journal encourages submissions that reflect rigorous scientific inquiry and uphold the highest standards of scholarship, thereby enhancing its role as a significant contributor to the field of internal medicine and endocrinology.

DIABETES & METABOLISM

Uncovering Breakthroughs in Diabetes and Metabolism
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

Archives of Endocrinology Metabolism

Exploring the intricacies of metabolism and endocrine health.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.